Related Experiment Videos
Endometrial carcinoma: paraaortic dissemination.
Andrea Mariani1, Gary L Keeney, Giacomo Aletti
1Section of Gynecologic Surgery, Mayo Clinic, Rochester, MN 55905, USA.
Gynecologic Oncology
|February 27, 2004
Summary
Positive pelvic lymph nodes and lymphovascular invasion are key predictors of endometrial cancer spread to paraaortic lymph nodes. Identifying these factors helps select high-risk patients for targeted therapy.
Area of Science:
- Gynecologic Oncology
- Pathology
- Surgical Oncology
Background:
- Endometrial carcinoma can disseminate to paraaortic lymph nodes (PAA), impacting patient prognosis.
- Identifying predictive factors for PAA metastasis is crucial for guiding treatment strategies.
Purpose of the Study:
- To identify pathological factors that predict tumor spread to paraaortic lymph nodes in endometrial cancer.
- To aid in selecting patients for specific surgical or radiotherapy interventions targeting the paraaortic area.
Main Methods:
- Analysis of a 10-year cohort of 566 patients with endometrial cancer.
- Identification of paraaortic lymph node (PAA) metastasis based on positive nodes or subsequent failure.
- Logistic regression analysis to determine independent predictive factors.
Main Results:
- Positive pelvic lymph nodes (OR=5.00) and lymphovascular invasion (LVI) (OR=1.99) were independent predictors of PAA metastasis.
- 47% of patients with positive pelvic lymph nodes had PAA metastasis, versus 2% with negative nodes.
- Patients with negative pelvic lymph nodes and LVI had only a 0.8% risk of PAA metastasis.
Conclusions:
- Positive pelvic lymph nodes and LVI identify a high-risk subgroup (approx. 1/6th of patients) who may benefit from PAA lymphadenectomy or adjuvant therapy.
- Patients with positive pelvic lymph nodes warrant consideration for pelvic and paraaortic radiotherapy or surgical restaging.